טוען...
Recent Advances in Systemic Therapies for Advanced Hepatocellular Carcinoma
PURPOSE OF REVIEW: This paper aims to summarize the data of recently completed and key ongoing clinical trials of systemic agents for advanced hepatocellular carcinoma (aHCC). In particular, the review focuses on ongoing checkpoint inhibitor combination trials and promising studies combining tyrosin...
שמור ב:
| הוצא לאור ב: | Curr Hepatol Rep |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer US
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7848044/ https://ncbi.nlm.nih.gov/pubmed/33552839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11901-021-00560-2 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|